Tomoharu Sugie

Summary

Publications

  1. ncbi request reprint A case of ductal carcinoma with squamous differentiation in malignant phyllodes tumor
    Tomoharu Sugie
    Department of Surgery, Shiga Medical Center for Adults, Japan
    Breast Cancer 14:327-32. 2007
  2. pmc Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid
    Atif S M Idrees
    Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Cancer Sci 104:536-42. 2013
  3. pmc Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells
    Tomoharu Sugie
    Department of Surgery, Graduate School of Medicine, Kyoto University, Yoshidakonoe cho, Sakyo ku, Kyoto, 606 8501, Japan
    Cancer Immunol Immunother 62:677-87. 2013
  4. ncbi request reprint [Two patients with StageIV gastric cancer responding to combination therapy with S-1 and low-dose CDDP after reduction surgery]
    Tomoharu Sugie
    Dept of Surgery, Kyoto Police Hospital
    Gan To Kagaku Ryoho 34:765-8. 2007
  5. ncbi request reprint [A case of HER2-positive metastatic breast cancer responding to trastuzumab plus gemcitabine combination therapy]
    Tomoharu Sugie
    Department of Surgery, Kyoto Police Hospital
    Gan To Kagaku Ryoho 35:683-6. 2008

Collaborators

  • Atif S M Idrees
  • Haruki Okamura
  • Yoshimasa Tanaka
  • Craig T Morita
  • Kaoru Murata-Hirai
  • Chiyomi Inoue
  • Masakazu Toi
  • Nagahiro Minato

Detail Information

Publications5

  1. ncbi request reprint A case of ductal carcinoma with squamous differentiation in malignant phyllodes tumor
    Tomoharu Sugie
    Department of Surgery, Shiga Medical Center for Adults, Japan
    Breast Cancer 14:327-32. 2007
    ..This is an extremely rare case of carcinosarcoma and the histopathological findings and review of the literature are discussed...
  2. pmc Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid
    Atif S M Idrees
    Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Cancer Sci 104:536-42. 2013
    ....
  3. pmc Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells
    Tomoharu Sugie
    Department of Surgery, Graduate School of Medicine, Kyoto University, Yoshidakonoe cho, Sakyo ku, Kyoto, 606 8501, Japan
    Cancer Immunol Immunother 62:677-87. 2013
    ..These results demonstrate that Zol can elicit immunological responses by γδ T cells from early-stage breast cancer patients, but that frequent in vivo treatment reduces Vγ2Vδ2 T cell numbers and their responsiveness to stimulation...
  4. ncbi request reprint [Two patients with StageIV gastric cancer responding to combination therapy with S-1 and low-dose CDDP after reduction surgery]
    Tomoharu Sugie
    Dept of Surgery, Kyoto Police Hospital
    Gan To Kagaku Ryoho 34:765-8. 2007
    ..The patients did not experience grade 3 or more adverse events and received this regimen as an outpatient. These results suggest that combination therapy with S-1 and low-dose CDDP is effective against advanced gastric cancer...
  5. ncbi request reprint [A case of HER2-positive metastatic breast cancer responding to trastuzumab plus gemcitabine combination therapy]
    Tomoharu Sugie
    Department of Surgery, Kyoto Police Hospital
    Gan To Kagaku Ryoho 35:683-6. 2008
    ..The adverse event during this treatment was minor, and PS was sufficiently maintained. These results suggest that trastuzumab plus gemcitabine combination therapy is effective for HER2-positive metastatic breast cancer...